Inventor · disambiguated record
Richard D. Caldwell
Also filed as: CALDWELL RICHARD · CALDWELL RICHARD DANA · Caldwell richard d
33 granted patents·5 pending applications·138 citations·filing 2006–2024
96Inventor score
Top patents by PatentIndex Score
38 records- 0192US10166250B2Bicyclic aryl sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2017·Granted Jan 1, 2019·9 cites·11 claims
- 0292US9572824B2Bicyclic aryl sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2015·Granted Feb 21, 2017·10 cites·14 claims
- 0392US8802659B2Bicyclic aryl sphingosine 1-phosphate analogsTHOMAS JERMAINE·Filed 2010·Granted Aug 12, 2014·20 cites·24 claims
- 0491US9827258B2Bicyclic aryl sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2017·Granted Nov 28, 2017·8 cites·10 claims
- 0591US9186367B2Bicyclic aryl sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2014·Granted Nov 17, 2015·15 cites·14 claims
- 0689US10329270B2Heteroaryl compounds as BTK inhibitors and uses thereofMERCK PATENT GMBH·Filed 2014·Granted Jun 25, 2019·16 cites·3 claims
- 0786US12139487B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2023·Granted Nov 12, 2024·1 cites·102 claims
- 0884US9765075B2Substituted bridged urea analogs as sirtuin modulatorsGLAXOSMITHKLINE LLC·Filed 2014·Granted Sep 19, 2017·2 cites·4 claims
- 0984US9340527B2S1P modulating agentsTHOMAS JERMAINE·Filed 2012·Granted May 17, 2016·6 cites·38 claims
- 1084US9181191B2Heterobicyclic sphingosine 1-phosphate analogsBIOGEN IDEC INC·Filed 2012·Granted Nov 10, 2015·3 cites·38 claims
- 1184US8158665B2Farnesoid X receptor agonistsCALDWELL RICHARD·Filed 2010·Granted Apr 17, 2012·12 cites·15 claims
- 1282US8349849B2Heterobicyclic sphingosine 1-phosphate analogsBIOGEN IDEC INC·Filed 2009·Granted Jan 8, 2013·6 cites·21 claims
- 1381US10266528B22-oxo-imidazopyridines as reversible BTK inhibitors and uses thereofMERCK PATENT GMBH·Filed 2017·Granted Apr 23, 2019·3 cites·18 claims
- 1481US10034869B2S1P modulating agentsBIOGEN MA INC·Filed 2017·Granted Jul 31, 2018·2 cites·18 claims
- 1580US9808449B2S1P modulating agentsBIOGEN MA INC·Filed 2015·Granted Nov 7, 2017·2 cites·21 claims
- 1680US7705028B2Farnesoid X receptor agonistsGLAXOSMITHKLINE LLC·Filed 2006·Granted Apr 27, 2010·6 cites·18 claims
- 1779US10253023B2Heteroaryl compounds as BTK inhibitors and uses thereofMERCK PATENT GMBH·Filed 2015·Granted Apr 9, 2019·3 cites·17 claims
- 1878US10005784B2Pyridines, pyrimidines, and pyrazines, as BTK inhibitors and uses thereofMERCK PATENT GMBH·Filed 2017·Granted Jun 26, 2018·2 cites·15 claims
- 1977US8546359B2Bicyclic aryl sphingosine 1-phosphate analogsCaldwell richard d·Filed 2012·Granted Oct 1, 2013·4 cites·31 claims
- 2076US10894040B2S1P modulating agentsBIOGEN MA INC·Filed 2019·Granted Jan 19, 2021·0 cites·20 claims
- 2176US9834558B2Substituted bridged urea analogs as sirtuin modulatorsGLAXOSMITHKLINE LLC·Filed 2014·Granted Dec 5, 2017·2 cites·2 claims
- 2275US9738648B2Pyridines, pyrimidines, and pyrazines, as BTK inhibitors and uses thereofMERCK PATENT GMBH·Filed 2014·Granted Aug 22, 2017·2 cites·13 claims
- 2374US10493073B2Heteroaryl compounds as BTK inhibitors and uses thereofMERCK PATENT GMBH·Filed 2018·Granted Dec 3, 2019·1 cites·8 claims
- 2474US8269043B2Bicyclic aryl sphingosine 1-phosphate analogsCaldwell richard d·Filed 2009·Granted Sep 18, 2012·2 cites·19 claims
- 2573US11098041B2Heteroaryl compounds as BTK inhibitors and uses thereofMERCK PATENT GMBH·Filed 2019·Granted Aug 24, 2021·1 cites·10 claims
- 2671US2025066354A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2766US2019209592A1Bicyclic aryl sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2018·Application pending·0 cites
- 2865US10406144B2SIP modulating agentsBIOGEN MA INC·Filed 2018·Granted Sep 10, 2019·0 cites·18 claims
- 2965US2018044338A1Substituted bridged urea analogs as sirtuin modulatorsGLAXOSMITHKLINE LLC·Filed 2017·Application pending·0 cites
- 3062US10590135B2Substituted bridged urea analogs as sirtuin modulatorsGLAXOSMITHKLINE LLC·Filed 2015·Granted Mar 17, 2020·0 cites·11 claims
- 3160US10081646B2Heterobicyclic sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2017·Granted Sep 25, 2018·0 cites·26 claims
- 3255US9708353B2Heterobicyclic sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2015·Granted Jul 18, 2017·0 cites·29 claims
- 3354US7723393B2Cycloalkylidene compounds as selective estrogen receptor modulatorsGLAXOSMITHKLINE LLC·Filed 2006·Granted May 25, 2010·0 cites·7 claims
- 3448US10012650B2Assays for BTK inhibitorsMERCK PATENT GMBH·Filed 2015·Granted Jul 3, 2018·0 cites·4 claims
- 3547US10045985B2Heteroaryl compounds as BTK inhibitors and uses thereofMERCK PATENT GMBH·Filed 2016·Granted Aug 14, 2018·0 cites·13 claims
- 3645US12415803B2Fused imidazopyridines as reversible inhibitors of Brutons Tyrosine Kinase (BTK)MERCK PATENT GMBH·Filed 2019·Granted Sep 16, 2025·0 cites·20 claims
- 3743US2009093464A1Naphthalene Derivatives as Modulators of the Glucocorticoid ReceptorSMITHKLINE BEECHMA CORP·Filed 2006·Application pending·0 cites
- 3839US2010261772A1Cycloalkylidene Compounds As Selective Estrogen Receptor ModulatorsFANG JING·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Richard D. Caldwell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →